Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen L Neville-Webbe

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Postgraduate Medical Journal|May 13, 2016
Patterns of acute oncology admissions: an exploratory analysis of over 7000 patient episodesHelen L Neville-Webbe, Helen Wong, Ernie Marshall
Seminars in Oncology|August 5, 2010
Potential anticancer properties of bisphosphonatesHelen L Neville-Webbe, Michael Gnant, Robert E Coleman
Anti-Cancer Drugs|August 13, 2005
Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitroJulia K L Woodward, Helen L Neville-Webbe, Robert E Coleman, et al.
International Journal of Cancer|September 30, 2004
Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cellsHelen L Neville-Webbe, Amin Rostami-Hodjegan, Catherine A Evans, et al.
Breast Cancer Research and Treatment|September 13, 2005
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?Ingunn Holen, Simon S Cross, Helen L Neville-Webbe, et al.
International Journal of Cancer|November 16, 2005
Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?Simon S Cross, Zhiyong Yang, Nicola J Brown, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Postgraduate Medical Journal|May 13, 2016
Patterns of acute oncology admissions: an exploratory analysis of over 7000 patient episodesHelen L Neville-Webbe, Helen Wong, Ernie Marshall
Seminars in Oncology|August 5, 2010
Potential anticancer properties of bisphosphonatesHelen L Neville-Webbe, Michael Gnant, Robert E Coleman
Anti-Cancer Drugs|August 13, 2005
Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitroJulia K L Woodward, Helen L Neville-Webbe, Robert E Coleman, et al.
International Journal of Cancer|September 30, 2004
Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cellsHelen L Neville-Webbe, Amin Rostami-Hodjegan, Catherine A Evans, et al.
Breast Cancer Research and Treatment|September 13, 2005
Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?Ingunn Holen, Simon S Cross, Helen L Neville-Webbe, et al.
International Journal of Cancer|November 16, 2005
Osteoprotegerin (OPG)--a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?Simon S Cross, Zhiyong Yang, Nicola J Brown, et al.
Pageof 1